-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

503.O1.6 503. Clonal Hematopoiesis: Aging and Inflammation

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
ALL, HSCs, Leukemia, Diseases, MDS, Biological Processes, DNA damage, Technology and Procedures, Cell Lineage, epigenetics, gene editing, Lymphoid Malignancies, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, hematopoiesis, inflammation, molecular testing, NGS, pathogenesis
Sunday, December 6, 2020: 12:00 PM-1:30 PM
Moderators:
Lukasz P. Gondek, MD, PhD, Johns Hopkins and George S. Vassiliou, MD, PhD, FRCPath, MRCP, Wellcome - MRC Cambridge Stem Cell Institute, Wellcome Trust Sanger Institute
Disclosures:
Vassiliou: Kymab Ltd - Monoclonal antibody company. Currently not working in myeloid cancers or clonal haematopoiesis.: Consultancy.
12:00 PM

Serine Avagyan, MD, PhD1, Jonathan E Henninger2*, William P. Mannherz3*, Meeta Mistry4*, Song P. Yang, PhD3*, Margaret Weber3*, Jessica Moore3* and Leonard I. Zon, MD5

1Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, MA
2Biological and Biomedical Sciences Program, Harvard University, Cambridge, MA
3Boston Children's Hospital, Boston
4Bioinformatics Core, Harvard T.H. Chan School of Public Health, Boston, MA
5Stem Cell Program and Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA

12:15 PM

Taehoon Shin1*, Shirley Chen, BS2*, Stefan Cordes, MD, PhD3, Yifan Zhou, MS2*, Byung-Chul Lee, PhD2*, Aisha Aljanahi, BS2*, So Gun Hong, PhD2*, Robert E. Donahue, VMD4*, Kyung-Rok Yu, PhD2 and Cynthia E. Dunbar, MD2

1Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institute of Health, BETHESDA, MD
2Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institute of Health, Bethesda, MD
3Translational Stem Cell Biology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
4Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

12:30 PM

Juliette Roels1,2,3*, Morgan Thénoz1,3*, Bronisława Szarzyńska4*, Mattias Landfors5*, Stien De Coninck1,6*, Lisa Demoen1,3*, Lien Provez1,3*, Anna Kuchmiy6*, Steven Strubbe6*, Lindy Reunes1,2,3*, Tim Pieters, PhD1,2,3*, Filip Matthijssens, PhD1,3*, Wouter Van Loocke1,3*, Tim Lammens, PhD7,8,9*, Barbara De Moerloose, MD, PhD2,9,10*, Marc R. Mansour, MD, PhD11*, Utpal Dave, MD12,13, Steven Goossens, PhD6, David J. Curtis, MBBS, PhD14, Tom Taghon, PhD6*, Małgorzata Dawidowska, PhD4*, Sofie Degerman, PhD5* and Pieter Van Vlierberghe, PhD1,2,3

1Center for Medical Genetics, Ghent University, Ghent, Belgium
2Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium
3Department for Biomolecular Medicine, Ghent University, Ghent, Belgium
4Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland
5Department of Medical Biosciences, Medical and Clinical Genetics, Umeå University, Umeå, Sweden
6Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
7Department of Pediatric Hemato-oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
8Cancer Research Institute Ghent (CRIG), Ghent, Belgium
9Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
10Belgium Society of Paediatric Hematology Oncology, Ghent, Belgium
11Cancer Institute, Department of Haematology, University College London, London, United Kingdom
12Division of Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN
13IU Melvin and Bren Simon Cancer Center; Division of Hematology/Oncology, Vanderbilt University Medical Center, Indianapolis, IN
14Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia

12:45 PM

Ryunosuke Saiki, MD1*, Tetsuichi Yoshizato, MD, PhD1, Yasuhito Nannya, MD, PhD1, Yukihide Momozawa, DVM, Ph.D2*, Chikashi Terao, MD, PhD3*, Yuichi Shiraishi, PhD4*, Kenichi Chiba5*, Hiroko Tanaka6*, Atsushi Niida, PhD7*, Seiya Imoto, PhD8*, Koichi Matsuda, MD, PhD9*, Takayuki Morisaki, MD, PhD10*, Yoshinori Murakami, MD, PhD10*, Yoichiro Kamatani, MD, Ph.D3,9*, Michiaki Kubo, MD, Ph.D11*, Satoru Miyano, PhD6*, Hideki Makishima, MD, PhD1 and Seishi Ogawa, MD, PhD1,12,13

1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
3Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
4Center for Cancer Genomics and Advanced Therapeutics, National Cancer Center Research Institute, Tokyo, Japan
5Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan
6Department of Integrated Data Science, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
7Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
8Health Intelligence Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan
9Department of Computational Biology and Medical Sciences, Graduate school of Frontier Sciences, The University of Tokyo, Tokyo, Japan
10Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
11RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
12Department of Medicine, Center for Haematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
13Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan

1:00 PM

Teng Gao1*, Ryan Ptashkin, MS2*, Kelly L. Bolton, MD, PhD3, Christopher Fong, PhD4*, Barbara Spitzer, MD5, Kamal Menghrajani, MD3, Juan E. Arango Ossa, BS6*, Yangyu Zhou, BS6*, Elsa Bernard, PhD7*, Max Levine, MS8*, Juan Medina, MS4*, Yanming Zhang, MD9,10, Sebastià Franch-Expósito, PhD11*, Minal A Patel, MPH6*, Lior Braunstein, MD12*, Daniel Kelly, MS13*, Mariko Yabe, MD, PhD14, Ryma Benayed, PhD2*, Nicole M Caltabellotta, BA6*, John Philip, BA, MS15*, Ederlinda Paraiso16*, Simon Mantha, MD, MPH17, David B. Solit, MD18*, Luis Alberto Diaz, MD19*, Michael F. Berger, PhD20*, Virginia M. Klimek, MD21, Ross L. Levine, MD4, Ahmet Zehir, PhD2*, Sean Devlin, PhD22* and Elli Papaemmanuil, PhD6,23

1Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Pediatrics, BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
6Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
7Center for Molecular Oncology, Center for Heme Malignancies and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA, New York, NY
8Memorial Sloan Kettering Cancer Institute, New York, NY
9Department of Pathology, Memorial Sloan Kettering Cancer Center, Chicago, IL
10Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
11Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
12Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
13Information Systems, Memorial Sloan Kettering Cancer Center, New York, NY
14Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
15Department of Health Informatics, Memorial Sloan Kettering Cancer Center, New York, NY
16Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
17Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York, NY
18Department of Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY
19Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
20Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
21Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
22Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
23Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

1:15 PM

Sebastià Franch-Expósito, PhD1*, Preethi Srinivasan, PhD1*, Ryan Ptashkin, MS2*, Chaitanya Bandlamudi, PhD1*, Kelly L. Bolton, MD, PhD3, Erika Gedvilaite2*, Kamal Menghrajani, MD3, Diana Mandelker, MD, Ph.D2*, Elizabeth Comen, MD3*, Larry Norton, MD3*, Ryma Benayed, PhD2*, Teng Gao4,5*, Elli Papaemmanuil, PhD6,7, Barry S Taylor, PhD1,8,9*, Ross L. Levine, MD3,4,9, Michael F. Berger, PhD1,2,9* and Ahmet Zehir, PhD2*

1Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
5Computational Oncology Service, Department of Epidemiology & Biostatistics, Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
6Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York
75Computational Oncology Service, Department of Epidemiology & Biostatistics, Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
9Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY

*signifies non-member of ASH